- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED Apr 10, 2024
Companys with strong funding and high growth potential
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
S1GE34 | US$56.70 | 6.7% | n/a | US$43.2b | US$56.74 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
A1RG34 | €78.88 | -1.2% | n/a | €21.1b | €97.33 | PS17.9x | E56.3% | n/a | Pharmaceuticals & Biotech | ||
S1RP34 | US$31.86 | -1.0% | -8.8% | US$11.9b | US$41.52 | PS9.5x | E42.3% | n/a | Pharmaceuticals & Biotech | ||
B1GN34 | US$30.80 | 0% | -41.4% | US$15.6b | US$55.25 | PS6.4x | E56.2% | n/a | Pharmaceuticals & Biotech | ||
E2XA34 | US$28.47 | 0% | -12.9% | US$13.4b | US$34.23 | PS5.3x | E61.5% | n/a | Pharmaceuticals & Biotech |
Page 1 of 1